STAA - STAAR Surgical downgraded to market perform by William Blair

2023-06-07 16:32:14 ET

William Blair has lowered its rating on STAAR Surgical ( NASDAQ: STAA ) to market perform citing a potential delay in US market inflection for the implantable lens maker.

"Overall, while we continue to think 10%-plus penetration is achievable in the United States, we believe an inflection in adoption and growth is likely to take more time than previously anticipated," William Blair analysts wrote in a note.

The analysts added that they continue to see overall company growth at 20%-plus, but were downgrading the stock until they gain "greater visibility on the geographic outlook."

More on STAAR:I See Opportunity In STAAR Surgical

STAAR Surgical: Revising To Hold Until Starting Valuations Improve (Rating Downgrade)

STAAR Surgical Company ( STAA ) Q1 2023 Earnings Call Transcript

For further details see: